Abstract |
Human T cell leukemia virus type-1 (HTLV-1) is prevalent worldwide with foci of high prevalence. However, to date no effective vaccine or drug against HTLV-1 infection has been developed. In efforts to define the role of antibodies in the control of HTLV-1 infection, we capitalized on the use of our previously defined anti-gp46 neutralizing monoclonal antibody (mAb) (clone LAT-27) and high titers of human anti-HTLV-1 IgG purified from HAM/TSP patients (HAM- IgG). LAT-27 and HAM- IgG completely blocked syncytium formation and T cell immortalization mediated by HTLV-1 in vitro. The addition of these antibodies to cultures of CD8(+) T cell-depleted peripheral blood mononuclear cells (PBMCs) from HAM/TSP patients at the initiation of culture not only decreased the numbers of Tax-expressing cells and the production of HTLV-1 p24 but also inhibited the spontaneous immortalization of T cells. Coculture of in vitro-HTLV-1-immortalized T cell lines with autologous PBMCs in the presence of LAT-27 or HAM- IgG, but not an F(ab')2 fragment of LAT-27 or nonneutralizing anti-gp46 mAbs, resulted in depletion of HTLV-1-infected cells. A 24-h (51)Cr release assay showed the presence of significant antibody-dependent cellular cytotoxicity (ADCC) activity in LAT-27 and HAM- IgG, but not F(ab')2 of LAT-27, resulting in the depletion of HTLV-1-infected T cells by autologous PBMCs. The depletion of natural killer (NK) cells from the effector PBMCs reduced this ADCC activity. Altogether, the present data demonstrate that the neutralizing and ADCC-inducing activities of anti-HTLV-1 antibodies are capable of reducing infection and eliminating HTLV-1-infected cells in the presence of autologous PBMCs.
|
Authors | Yuetsu Tanaka, Yoshiaki Takahashi, Reiko Tanaka, Akira Kodama, Hideki Fujii, Atsuhiko Hasegawa, Mari Kannagi, Aftab A Ansari, Mineki Saito |
Journal | AIDS research and human retroviruses
(AIDS Res Hum Retroviruses)
Vol. 30
Issue 6
Pg. 542-52
(Jun 2014)
ISSN: 1931-8405 [Electronic] United States |
PMID | 24524420
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Neutralizing
- Antibodies, Viral
- Immunoglobulin G
|
Topics |
- Antibodies, Neutralizing
(immunology)
- Antibodies, Viral
(immunology)
- Antibody-Dependent Cell Cytotoxicity
- Cell Survival
- Human T-lymphotropic virus 1
(immunology)
- Humans
- Immunoglobulin G
(immunology)
- Killer Cells, Natural
(immunology)
- Leukocytes, Mononuclear
(physiology, virology)
|